SynBioBeta Speaker
Kevin Flyangolts
CEO
Aclid
YEAR
25
May 2025, SynBioBeta
Speaker
Kevin is founder and CEO of Aclid, a security and safety platform for biotechs. Aclid's platform helps biotechs comply with trade controls, international biosecurity and biosafety regulations, and federal funding requirements. The company works with DNA and RNA manufacturers in biosecurity, life sciences research labs in biosafety, and with US defense in biosurveillance.
SynBioBeta 2025 - Session Speaker
The Biological "Zero-Day" that Catalyzed a New Biosecurity Community
As synthetic biology and AI capabilities continue to expand and combine, biosecurity threats are becoming both more widespread and more difficult to mitigate. This panel will discuss these challenges in the context of a recent positive case study, in which multiple organizations collaborated to address an AI-based biological "zero day" threat using practices adapted from cybersecurity. We will further discuss how this collaboration has since matured into a larger effort to develop international standards for nucleic acid biosecurity screening, and close with remarks on emerging challenges in biosecurity.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,595
USD
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Before Midnight Thu, Dec 4
Regular Rate
$1,995
Purchase Pass
Purchase Pass
BLACK FRIDAY DEAL
Buy 1 Conference Pass, Get 1 Expo Pass Free
Conference Pass
1,595
USD
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Before Midnight Thu, Dec 4
Regular Rate
$1,995
Purchase Pass
Purchase Pass
BLACK FRIDAY DEAL
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates